GO:0033962 P-body assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• P-body assembly (GO:0033962) is the biological process by which proteins and RNA molecules aggregate, arrange and bond together to form a cytoplasmic mRNA processing body.
• DDX6 is a central driver of P-body assembly; its repression complexes, rather than decay or Ataxin2/2L complexes, are required for this process.
• P-body assembly is controlled by competing protein-RNA interaction networks that determine multiphase intracellular organization.
• EDC4 scaffolds P-body assembly through its C-terminal domain and links P-body dynamics to p53-mediated tumor suppression.
• Praja2 regulates P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6.
• P-body assembly can be modulated by antisense oligonucleotides that bind P-body proteins, and it is tightly connected to stress granule dynamics [1,8].
Description
P-body assembly (GO:0033962) is the biological process that builds cytoplasmic mRNA processing bodies (P-bodies) from proteins and RNA molecules. P-bodies are membraneless organelles that concentrate translationally repressed mRNAs and the machinery for mRNA decay, and their assembly is a paradigm for how cells organize biochemistry without membranes [3,4]. Understanding P-body assembly matters because these structures influence mRNA fate, translation output and stress responses, and their dysregulation is linked to cancer and other diseases [2,5]. The process is not a simple linear pathway; it emerges from multivalent protein-protein and protein-RNA interactions that drive phase separation and the formation of distinct intracellular compartments [4,7]. Key assembly factors include DDX6, which is required for P-body formation and also modulates stress granule assembly, composition and docking [1,6]. EDC4 provides a structural scaffold for P-body assembly and connects P-body dynamics to p53-mediated tumor suppression. In glioblastoma, Praja2 controls P-body assembly and translation by ubiquitylating DDX6, showing that assembly is actively regulated in disease contexts. Because P-body assembly sits at the intersection of RNA decay, translational control and organelle biology, it is a high-value target for functional genomics and CRISPR-based dissection [3,6].
P-body assembly At A Glance
| GO ID | GO:0033962 |
|---|---|
| GO term | P-body assembly |
| Ontology | biological_process |
| Synonym | cytoplasmic mRNA processing body assembly; P body assembly; P body biogenesis |
| Major function | Formation of cytoplasmic mRNA processing bodies from proteins and RNA |
| Cellular context | Cytoplasm; membraneless organelle |
| Key drivers | DDX6 repression complexes, EDC4, competing protein-RNA networks |
| Disease relevance | Cancer (glioblastoma, p53-mediated tumor suppression), stress-related pathology |
| Research methods | CRISPR KO/point mutation/knock-in, imaging, RNA-seq, proteomics, Ribo-seq |
What Is GO:0033962?
P-body assembly is the aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body. In other words, it is the self-organization process that creates a membraneless cytoplasmic granule enriched in translationally repressed mRNAs and decay factors [3,4].
Why Is P-body assembly Important in Cell Biology?
P-body assembly is important because it determines how cells package translationally repressed mRNAs and decay machinery into a dedicated cytoplasmic compartment, thereby influencing gene expression at the post-transcriptional level [3,4]. Disrupting assembly factors such as DDX6 or EDC4 alters P-body formation and can affect tumor suppression and translation in cancer cells [2,5,6]. Because P-bodies are membraneless and dynamic, their assembly provides a tractable model for studying phase separation and organelle biogenesis in living cells [4,7].
• Controls post-transcriptional gene regulation by concentrating repressed mRNAs and decay factors.
• DDX6 is required for P-body assembly and also influences stress granule assembly and docking [1,6].
• EDC4 scaffolds P-body assembly and links P-body dynamics to p53-mediated tumor suppression.
• Praja2-mediated ubiquitylation of DDX6 regulates P-body assembly and translation in glioblastoma.
• Competing protein-RNA interaction networks govern multiphase intracellular organization, including P-bodies.
• Composition-dependent thermodynamics explains how phase separation contributes to P-body formation.
• Antisense oligonucleotides can bind P-body proteins and mediate P-body assembly, linking pharmacology to assembly.
• P-body assembly is a model for membraneless organelle biogenesis and gene regulation.
What Happens During P-body assembly?
Initiation by DDX6 repression complexes
In simple terms: The process starts when a key protein called DDX6 and its partners gather to seed a new P-body.
P-body assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L complexes, establishing DDX6 as a central initiation factor. DDX6 also modulates P-body and stress granule assembly, composition and docking, indicating that it coordinates multiple steps of granule formation. In glioblastoma, Praja2 controls P-body assembly by non-proteolytic ubiquitylation of DDX6, showing that post-translational modification of DDX6 regulates this initiation step.
Scaffolding by EDC4
In simple terms: A scaffold protein called EDC4 helps hold the assembling P-body together.
The EDC4 C-terminal domain scaffolds P-body assembly and links P-body dynamics to p53-mediated tumor suppression. This scaffolding function indicates that EDC4 provides structural organization during assembly, beyond its role in mRNA decapping.
Competing protein-RNA interaction networks and phase separation
In simple terms: Many proteins and RNAs compete to bind each other, and this competition drives the formation of distinct droplets inside the cell.
Competing protein-RNA interaction networks control multiphase intracellular organization, including P-body formation. Composition-dependent thermodynamics of intracellular phase separation explains how the mixture of proteins and RNAs determines whether a P-body forms and how it behaves. These principles show that P-body assembly is an emergent property of many weak interactions rather than a single linear pathway [4,7].
Modulation by antisense oligonucleotides and stress
In simple terms: Certain drugs and stress conditions can change how P-bodies assemble.
Phosphorothioate antisense oligonucleotides bind P-body proteins and mediate P-body assembly, demonstrating that exogenous molecules can influence this process. DDX6 modulates both P-body and stress granule assembly, composition and docking, linking P-body assembly to stress granule biology.
Key Genes Involved in GO:0033962 P-body assembly
The following genes and proteins are experimentally implicated in P-body assembly (GO:0033962) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DDX6 | Required for P-body assembly; modulates stress granule assembly, composition and docking | Core assembly factor; target for KO and point-mutation studies [1,6] |
| EDC4 | C-terminal domain scaffolds P-body assembly; links P-body dynamics to p53-mediated tumor suppression | Scaffold and tumor-suppression link; target for domain-mapping knock-in |
| PRAJA2 | Non-proteolytic ubiquitylation of DDX6 controls P-body assembly and translation in glioblastoma | Disease-specific regulator; target for KO/overexpression in glioblastoma models |
| ATXN2 | Ataxin2/2L complexes are not required for P-body assembly | Negative control for assembly requirements |
| ATXN2L | Ataxin2/2L complexes are not required for P-body assembly | Negative control for assembly requirements |
| DCP1A | Decapping complex component associated with P-bodies | Context-dependent role in P-body biology |
| DCP2 | Decapping enzyme associated with P-bodies | Decay machinery not strictly required for assembly |
| XRN1 | Exonuclease associated with P-bodies | Decay machinery not strictly required for assembly |
| LSM14A | RNA-binding protein in P-body-related complexes | Candidate modulator of assembly |
| EIF4E | Translation initiation factor that can localize to P-bodies | Links translation repression to assembly |
| AGO2 | Argonaute protein associated with P-bodies | Links RNA silencing to P-body biology |
| TNRC6A | GW182 family protein in P-body-related silencing complexes | Candidate scaffold/assembly modulator |
| TNRC6B | GW182 family protein in P-body-related silencing complexes | Candidate scaffold/assembly modulator |
| TNRC6C | GW182 family protein in P-body-related silencing complexes | Candidate scaffold/assembly modulator |
| DDX3X | RNA helicase implicated in RNA granule biology | Candidate modifier of P-body assembly |
| G3BP1 | Stress granule protein with functional interplay with P-bodies | Links P-body and stress granule assembly |
| G3BP2 | Stress granule protein with functional interplay with P-bodies | Links P-body and stress granule assembly |
| TP53 | Tumor suppressor functionally linked to P-body dynamics via EDC4 | Connects P-body assembly to tumor suppression |
How Is P-body assembly Regulated?
P-body assembly is regulated by post-translational modification of core factors and by the composition of the protein-RNA mixture. Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6, showing that ubiquitylation of an assembly factor can regulate the process. DDX6 itself modulates P-body and stress granule assembly, composition and docking, indicating that its levels or activity set the threshold for assembly. EDC4 scaffolding links P-body dynamics to p53-mediated tumor suppression, connecting assembly to a major tumor-suppressor pathway. More broadly, competing protein-RNA interaction networks and composition-dependent thermodynamics determine whether P-bodies form and how they are organized [4,7]. Antisense oligonucleotides that bind P-body proteins can also mediate P-body assembly, revealing an exogenous route to modulate the process.
P-body assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DDX6 | Glioblastoma; P-body and stress granule assembly | DDX6 knockout and point-mutation cell models [1,2,6] |
| PRAJA2 | Glioblastoma; translation control | PRAJA2 knockout and overexpression in glioblastoma lines |
| EDC4 | p53-mediated tumor suppression | EDC4 domain knock-in and knockout models |
| TP53 | Tumor suppression linked to P-body dynamics | TP53 knockout with P-body imaging |
| ATXN2 | Neurodegeneration-related RNA biology | ATXN2 knockout as negative control for assembly |
P-body assembly in glioblastoma
Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6, directly linking a P-body assembly regulator to brain tumor biology. This suggests that P-body assembly status may influence translation programs in glioblastoma cells.
P-body assembly and p53-mediated tumor suppression
EDC4 C-terminal domain scaffolds P-body assembly and links P-body dynamics to p53-mediated tumor suppression, connecting assembly to a central tumor-suppressor pathway. Disruption of EDC4 scaffolding may therefore affect both P-body formation and tumor-suppressive responses.
P-body assembly and stress-related pathology
DDX6 modulates P-body and stress granule assembly, composition and docking, and P-bodies are membraneless organelles with roles in gene regulation [1,3]. Because stress granules and P-bodies are linked, conditions that alter stress granule biology may also affect P-body assembly [1,3].
From P-body assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is DDX6 required for P-body assembly? | DDX6 knockout cell line |
| Does ubiquitylation of DDX6 regulate assembly? | DDX6 point-mutation knock-in |
| Does EDC4 scaffolding link to p53? | EDC4 domain knock-in and knockout |
| How does DDX6 modulate stress granule docking? | Tagged DDX6 knock-in for imaging |
| Can overexpression drive assembly? | DDX6 or EDC4 overexpression [2,5] |
| Do antisense oligonucleotides mediate assembly? | Oligonucleotide treatment with P-body imaging |
How to Study the P-body assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | P-body number, size and composition | Visualizing assembly and docking [1,5] |
| Live-cell imaging | Dynamics of P-body formation | Tracking assembly over time |
| RNA-seq | Transcriptome changes upon assembly perturbation | Linking assembly to gene expression [2,5] |
| Ribo-seq | Translation efficiency | Measuring translation control by assembly factors |
| Proteomics | Protein composition and interactions | Defining assembly networks [4,5] |
| CRISPR knockout | Requirement of a gene for assembly | Testing DDX6, EDC4, PRAJA2 [2,5,6] |
| CRISPR knock-in | Effect of specific mutations or tags | Point mutations and tagged assembly factors [1,2] |
| Antisense oligonucleotide treatment | Exogenous modulation of assembly | Testing P-body protein binding |
Imaging P-body assembly
Fluorescence microscopy of P-body markers such as DDX6 and EDC4 allows direct visualization of assembly, composition and docking with stress granules [1,5]. Live-cell imaging of tagged assembly factors can reveal dynamics of P-body formation.
Transcriptomics and RNA-seq
RNA-seq can measure how loss or mutation of assembly factors changes the transcriptome and the set of mRNAs associated with P-bodies [2,5]. This helps link P-body assembly to post-transcriptional gene regulation.
Proteomics and interactomics
Proteomic analysis of P-body components can identify assembly-dependent protein interactions and composition changes [4,5]. Such studies help define the protein-RNA interaction networks that control assembly.
Translation profiling and Ribo-seq
Ribo-seq and polysome profiling can measure translation output when P-body assembly is perturbed, as shown for Praja2-DDX6 regulation in glioblastoma. This connects assembly status to translational control.
How CRISPR Can Be Used to Study GO:0033962 P-body assembly
Knockout
CRISPR knockout of DDX6 or EDC4 can test whether these factors are required for P-body assembly, as suggested by loss-of-function studies [5,6]. Knockout of PRAJA2 can test its role in glioblastoma P-body assembly.
Point Mutation
Point-mutation knock-in can dissect specific residues or domains, such as those controlling DDX6 ubiquitylation or EDC4 scaffolding [2,5]. This approach separates assembly functions from other activities of the same protein [2,5].
Knock-in
Tagged knock-in of DDX6 or EDC4 enables imaging of endogenous P-body assembly and docking with stress granules [1,5]. Domain knock-in can map which regions are sufficient for assembly.
Overexpression
Overexpression of assembly factors such as DDX6 or EDC4 can test whether increased levels drive P-body formation or alter composition [2,5]. Overexpression in disease models like glioblastoma can reveal context-specific effects.
How EDITGENE Supports P-body assembly Research
Researchers studying P-body assembly-related genes often need to determine whether a candidate gene is causally involved in assembly, how specific domains contribute, and whether its dysregulation drives disease. EDITGENE provides the CRISPR cell models and screening services needed to answer these questions with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for P-body assembly research.
Frequently Asked Questions About P-body assembly
What is P-body assembly?
P-body assembly (GO:0033962) is the aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body.
What genes are involved in P-body assembly?
Key genes include DDX6, EDC4 and PRAJA2, with DDX6 repression complexes being required for assembly [1,2,5,6].
Is DDX6 required for P-body assembly?
Yes, P-body assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L complexes.
How is P-body assembly regulated?
It is regulated by post-translational modification such as Praja2-mediated ubiquitylation of DDX6 and by competing protein-RNA interaction networks [2,4].
What is the role of EDC4 in P-body assembly?
The EDC4 C-terminal domain scaffolds P-body assembly and links P-body dynamics to p53-mediated tumor suppression.
How does P-body assembly relate to cancer?
Praja2 controls P-body assembly in glioblastoma, and EDC4 links P-body dynamics to p53-mediated tumor suppression [2,5].
What methods study P-body assembly?
Fluorescence microscopy, live-cell imaging, RNA-seq, Ribo-seq, proteomics and CRISPR knockout/knock-in are commonly used [1,2,4,5].
Can antisense oligonucleotides affect P-body assembly?
Yes, phosphorothioate antisense oligonucleotides bind P-body proteins and mediate P-body assembly.
What is the difference between P-bodies and stress granules?
Both are membraneless organelles, and DDX6 modulates P-body and stress granule assembly, composition and docking [1,3].
Why is P-body assembly important for gene regulation?
It concentrates translationally repressed mRNAs and decay factors, influencing post-transcriptional gene expression [3,4].
Conclusion
P-body assembly (GO:0033962) is a dynamic, multistep process driven by DDX6 repression complexes, EDC4 scaffolding and competing protein-RNA interaction networks [4,5,6]. Its regulation by ubiquitylation and its links to cancer and p53-mediated tumor suppression make it a compelling target for functional genomics [2,5]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with imaging and omics, provide the tools needed to dissect P-body assembly in health and disease [1,2,5].
References
- 1. Ripin N et al.. 2024. DDX6 modulates P-body and stress granule assembly, composition, and docking.. J Cell Biol 223(6) PMID: 38536035
- 2. Senatore E et al.. 2025. Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6.. EMBO Rep 26(9):2347-2377 PMID: 40148504
- 3. Hirose T et al.. 2023. A guide to membraneless organelles and their various roles in gene regulation.. Nat Rev Mol Cell Biol 24(4):288-304 PMID: 36424481
- 4. Sanders DW et al.. 2020. Competing Protein-RNA Interaction Networks Control Multiphase Intracellular Organization.. Cell 181(2):306-324.e28 PMID: 32302570
- 5. Cheng YH et al.. 2025. EDC4 C-terminal domain scaffolds P-body assembly and links P-body dynamics to p53-mediated tumor suppression.. RNA 31(8):1176-1194 PMID: 40360209
- 6. Ayache J et al.. 2015. P-body assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L complexes.. Mol Biol Cell 26(14):2579-95 PMID: 25995375
- 7. Riback JA et al.. 2020. Composition-dependent thermodynamics of intracellular phase separation.. Nature 581(7807):209-214 PMID: 32405004
- 8. Wang Y et al.. 2019. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.. Nucleic Acid Ther 29(6):343-358 PMID: 31429620
